Pete has over 20 years’ experience in patent litigation, handling complex and high value cases before the UK courts (including up to the Supreme Court) and the UPC. His cases are frequently international in nature, and he often works with legal advisers from across Europe, North America and Asia, contributing to and often co-ordinating multi-jurisdictional patent litigation strategies.

Pete has particular expertise in SEP/FRAND licensing disputes. He has been involved in a number of leading cases in the UK, including representing clients in two of the four FRAND determination cases in the UK that have gone to trial (Unwired Planet v Huawei, and Samsung v ZTE) and two of the FRAND cases to reach the UK Supreme Court (Unwired Planet v Huawei, and Tesla v Avanci and InterDigital).

Pete’s scientific background provides him with a firm understanding of technical issues. In addition to SEP/FRAND cases, he is experienced in working with a diverse range of technologies, including medical devices, pharmaceutical products and formulations, biotechnology, and engineering.

Pete is Chair of AIPPI’s Standing Committee on Enforcement, is a tutor on patent litigation on the Oxford Diploma in Intellectual Property Law and Practice course, and frequently speaks on IP-related issues at conferences.

Pete became a partner in 2016.

Key cases: 

• Tesla v InterDigital & Avanci (SEPs/FRAND licensing)
• Samsung v ZTE (SEPs/FRAND licensing)
• Ericsson v ASUSTeK (UPC – SEPs/FRAND licensing)
• Philip Morris v Nicoventures (heat-not-burn tobacco)
• Advanced Bionics v MED-EL (cochlear implants)
• Coloplast v Salts (ostomy devices)
• Unwired Planet v Huawei & Others (telecommunications / FRAND licensing)
• Garmin v Philips (GPS wearable devices)
• Varian v Elekta (MRI / radiotherapy devices)
• TCT v Ericsson (telecommunications)
• Mölnlycke v BSN Medical (wound dressings)
• ​Mylan v Sandoz (protein purification)
• Teva v Actavis (rasagiline)
• Icahn School of Medicine at Mount Sinai (SPCs – agalsidase beta)
• Corma v Hegler Plastik (extruded plastics)
• Eugen Seitz v KHS Corpoplast and Norgren (PET plastic technology)
• HTC v Apple (smartphones)
• Apple v Nokia (smartphones)
• Alan Nuttall v Fri-Jado (hot food merchandisers)
• Teva v Aventis (docetaxel formulations) 
• Roche v Chiron (SPCs – trastuzumab and enfuvirtide)*

*Prior to joining Powell Gilbert